Baker Ellis Asset Management LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% during the 1st quarter, HoldingsChannel reports. The firm owned 1,269 shares of the healthcare conglomerate’s stock after selling 30 shares during the period. Baker Ellis Asset Management LLC’s holdings in UnitedHealth Group were worth $472,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Accel Wealth Management purchased a new position in UnitedHealth Group during the 4th quarter worth $26,000. Atlas Private Wealth Advisors increased its holdings in shares of UnitedHealth Group by 46.2% in the 1st quarter. Atlas Private Wealth Advisors now owns 95 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 30 shares during the period. Sage Private Wealth Group LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $36,000. IronBridge Private Wealth LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $37,000. Finally, Costello Asset Management INC increased its holdings in shares of UnitedHealth Group by 500.0% in the 4th quarter. Costello Asset Management INC now owns 120 shares of the healthcare conglomerate’s stock valued at $42,000 after acquiring an additional 100 shares during the period. Institutional investors own 86.03% of the company’s stock.
In other news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, April 19th. The stock was sold at an average price of $391.25, for a total transaction of $978,125.00. Following the transaction, the director now directly owns 154,181 shares in the company, valued at approximately $60,323,316.25. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 619 shares of the company’s stock in a transaction that occurred on Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total value of $200,494.10. Following the completion of the transaction, the chief accounting officer now owns 31,908 shares in the company, valued at $10,335,001.20. The disclosure for this sale can be found here. In the last 90 days, insiders sold 20,420 shares of company stock valued at $7,532,962. 0.80% of the stock is owned by company insiders.
Shares of UnitedHealth Group stock opened at $405.90 on Tuesday. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.59. UnitedHealth Group Incorporated has a twelve month low of $273.71 and a twelve month high of $406.77. The business has a 50-day moving average price of $378.48 and a 200 day moving average price of $349.25. The firm has a market cap of $383.12 billion, a PE ratio of 23.31, a P/E/G ratio of 1.55 and a beta of 0.74.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $4.38 by $0.93. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The firm had revenue of $70.20 billion during the quarter, compared to analyst estimates of $69.13 billion. During the same quarter in the previous year, the business earned $3.72 EPS. UnitedHealth Group’s revenue for the quarter was up 9.0% compared to the same quarter last year. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 23rd. Investors of record on Monday, March 15th were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.23%. UnitedHealth Group’s dividend payout ratio is presently 33.09%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.